CNMD - コンメド (CONMED Corporation) コンメド



symbol CNMD
会社名 Conmed Corp. (コンメド)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 コンメッド(CONMED Corporation)は医療技術会社である。同社は外科用機器および関連機器の開発、製造および販売に従事する。同社は低侵襲性治療用外科用器具を提供する。同社の製品は整形外科、一般外科、婦人科、脳神経外科、胃腸病学などの専門分野で外科医・医師に使用される。同社の製品ラインは整形外科手術、一般外科手術、手術視覚化を含む。同社の整形外科用製品ラインにはスポーツ医学、動力付き外科用器具、スポーツ用の生物製剤と組織が含まれる。同社の製品は「Hall」、「CONMED Linvatec」、「Concept」、「Shutt」を含むブランドで販売される。   コンメドは米国の手術器具や装置に特化した大手医療品メ―カ―。内視鏡などの腹腔鏡手術や、そのほかの整形外科市場向けの受電手術器具、心臓モニタリング及び血液酸素化モニタリング用ECG電極製品、手術用電動ノコギリ、ドリル、発電機などを提供する。本社はニューヨーク州ウティカ。   CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
本社所在地 525 French Road Utica NY 13502 USA
代表者氏名 Mark E. Tryniski マークE.トゥリニスキ
代表者役職名 Independent Chairman of the Board
電話番号 +1 315-624-3215
設立年月日 25600
市場名 NASDAQ National Market System
ipoyear 1987年
従業員数 3100人
EBITDA EBITDA(百万ドル) 125.32100
終値(lastsale) 73.67
時価総額(marketcap) 2070919320.85
時価総額 時価総額(百万ドル) 259.956
売上高 売上高(百万ドル) 827.55600
企業価値(EV) 企業価値(EV)(百万ドル) 2485.742
当期純利益 当期純利益(百万ドル) 41.36900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 CONMED Corporation revenues increased 8% to $414.9M. Net income increased from $1.6M to $19.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Restructuring decrease from $19M (expense) to $0K Derivatives increase from $1.8M to $5.9M (income) Restructuring - COGS decrease from $1.5M (expense) to $0K.



   Orthopedic Implants Market Size Worth $67.23 Billion, Globally, by 2028 at 5.6% CAGR - Exclusive Research Report by The Insight Partners  2022/09/28 11:30:00 Benzinga
NEW YORK , Sept. 28, 2022 /PRNewswire/ -- The Insight Partners published latest research study on " Orthopedic Implants Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, End User, and Geography", the global orthopedic implants market size is expected to grow from $46.10 Billion in 2021 to $67.23 Billion by 2028; it is expected to grow at a CAGR of 5.6% from 2022 to 2028. Download Sample Brochure of Orthopedic Implants Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: Orthopedic Implants Market Report Scope, Segmentations, Regional & Country Scope: Report Coverage Details Market Size Value in US$ 46.10 Billion in 2021 Market Size Value by US$ 67.23 Billion by 2028 Growth rate CAGR of 5.6% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021 No. of Pages 150 Historical data available Yes Segments covered Product, Application, End User, and Geography Regional scope North America; Europe; Asia Pacific; Latin America; MEA Country scope US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends Companies Covered DJO Finance LLC; Johnson & Johnson (DePuy Synthes); Medtronic Plc; Zimmer Biomet Holdings, Inc.; Stryker Corporation; NuVasive, Inc.; CONMED Corporation; Smith and Nephew Plc; Arthrex, Inc.; Globus Medical, Inc.
   CONMED: Fairly Priced At Pre-Pandemic Market Cap (NYSE:CNMD)  2022/09/21 06:04:40 Seeking Alpha
CONMED continues to attract sellers this week as equity markets continue digesting the latest macroeconomic data. See why I rate CNMD stock a Hold.
   CONMED Corporation to Participate in a Fireside Chat at the Morgan Stanley Global Healthcare Conference  2022/09/06 20:05:00 Business Wire
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference at 5:15 p.m. ET on Tuesday, September 13, 2022. A live audio webcast of the fireside chat will be accessible through the “Investors” section of the Company’s website
   Top 5 2nd Quarter Trades of Jefferies Group LLC  2022/08/15 23:00:26 GuruFocus
Check out Jefferies Group Stock Picks » Download GuruFolio Report of Jefferies Group (Updated on 08/14/2022) Related Stocks: QQQ , WYNN , SPY , EMB , CNMD ,
   CONMED declares $0.20 dividend  2022/08/11 20:54:09 Seeking Alpha
CONMED (NYSE:CNMD) declares $0.20/share quarterly dividend, in line with previous.Forward yield 0.8%Payable Oct. 5; for shareholders of record Sept. 15; ex-div Sept.
   CONMED Corporation to Announce Second Quarter 2022 Financial Results on July 27, 2022  2022/07/05 20:05:00 Business Wire
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, July 27, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro
   Regenerative Medicines: Bone and Joint Applications Global Market Report 2022-2027: Featuring Key Players Bioventus, Conmed, Depuy Synthes Products, Medtronic, Seikagaku & Others  2022/06/27 17:30:00 Kwhen Finance
   Conmed Corp. Shares Close in on 52-Week Low - Market Mover  2022/06/17 00:00:00 Kwhen Finance
Conmed Corp. (CNMD) shares closed today at 1.5% above its 52 week low of $87.62, giving the company a market cap of $2B. The stock is currently down 37.5% year-to-date, down 35.2% over the past 12 months, and up 81.7% over the past five years. This week, the Dow Jones Industrial Average fell 7.2%, and the S&P 500 fell 8.7%. Trading Activity Trading volume this week was 4.5% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 3.6% lower than its 5-day moving average, 16.5% lower than its 20-day moving average, and 32.3% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 118.7% The company's stock price performance over the past 12 months lags the peer average by 57.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 19.3% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at Write to © 2020 Kwhen Inc.
   Conmed completes acquisition of medical devices company In2Bones  2022/06/13 20:16:02 Seeking Alpha
Conmed (CNMD) completed the acquisition of the medical devices company In2Bones Global.
   In 2022, Will CONMED Corporation (NYSE: CNMD) Be Bullish Or Bearish?  2022/06/02 17:00:00 Stocks Register
CONMED Corporation (NYSE:CNMD) shares, rose in value on Thursday, June 02, with the stock price up by 1.54% to the previous day’s close as strong demand from buyers drove the stock to $113.51. Actively observing the price movement in the recent trading, the stock is buoying the session at $111.79, falling within a range of … In 2022, Will CONMED Corporation (NYSE: CNMD) Be Bullish Or Bearish? Read More »
   The Global Powered Surgical Instruments Market Is Expected To Exhibit Strong Growth With a CAGR of 4.26% In The Coming Years, Assess DelveInsight  2022/03/01 18:00:00 Benzinga
New York, USA, March 01, 2022 (GLOBE NEWSWIRE) -- The Global Powered Surgical Instruments Market Is Expected To Exhibit Strong Growth With a CAGR of 4.26% In The Coming Years , Assess DelveInsight As per DelveInsight analysis, the Powered Surgical Instruments market is growing positively due to the factors such as an increase in geriatric population, having a high prevalence of bone disorders and ophthalmic conditions, and along with the increasing incidence of brain cancers as well increase in the number of trauma cases, and a parallel growth in product innovation. DelveInsight''s Powered Surgical Instruments Market Insights report provides the current and forecast Powered Surgical Instruments market, upcoming device innovation, individual leading Powered Surgical Instruments device companies market shares, challenges, drivers, barriers, and market trends and key Powered Surgical Instruments companies in the market. Key Takeaways from the Global Powered Surgical Instruments Market According to DelveInsight analysis, North America is expected to dominate the overall Powered Surgical Instruments market during the forecast period.
   Global Minimally Invasive Surgical Systems Market: Focus on Product Type, Application, End Users, 25 Countries'' Data, Patent Scenario, and Competitive Landscape - Analysis and Forecast, 2021-2031  2022/02/28 18:39:28 Benzinga
New York, Feb. 28, 2022 (GLOBE NEWSWIRE) -- announces the release of the report "Global Minimally Invasive Surgical Systems Market: Focus on Product Type, Application, End Users, 25 Countries'' Data, Patent Scenario, and Competitive Landscape - Analysis and Forecast, 2021-2031" - Market Segmentation • Product - Conventional Technologies (Endoscopes and Endoscopic Systems, Video and Visualization Systems, Capsule Endoscopy, Instruments and Accessories, Others), Surgical Robotics (Robotic Systems, Instruments and Accessories, Services) • Application - General Surgery, Urology Surgery, Gynecology Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Others • End User - Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics • Region - North America, Europe, Asia-Pacific, Latin America, Middle East and Africa Regional Segmentation • North America - U.S., Canada • Europe - Germany, France, Spain, U.
   Endoscopy Equipment Market : Analysis of Potential Market Opportunity Worth USD 39.3 Billion by 2026  2022/02/24 19:18:00 SBWire
Endoscopy Equipment Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow. Northbrook, IL -- ( SBWIRE ) -- 02/24/2022 -- This report aims to provide detailed insights into the global endoscopy equipment market . It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market. Expected Revenue Growth: The global endoscopy equipment market is projected to reach USD 39.3 billion by 2026 from USD 27.3 billion in 2021, at a CAGR of 7.5%. Download PDF Brochure: Key Factors Driving Market Growth: The key factors driving the growth of endoscopy equipment market include favorable government initiatives, rising number of hospitals and growing hospital investments in endoscopy facilities, technological advancements, and rising prevalence of diseases that require endoscopy.
   Conmed Posts Mixed Bag Q4 Earnings, Issues FY22 Outlook  2022/01/27 13:08:28 Benzinga
CONMED Corporation (NYSE: CNMD ) reported Q4 FY21 adjusted EPS of $1.07 , compared to $0.84 a year ago, and better than the consensus of $1.06. Sales for the quarter rose 8.4% Y/Y to $273.97 million, missing the consensus of $278.76 … Full story available on
   CONMED Corporation (CNMD) CEO Curt Hartman on Q4 2021 Results - Earnings Call Transcript  2022/01/27 00:24:08 Seeking Alpha

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 コンメド CNMD CONMED Corporation)


 twitter  (公式ツイッターやCEOツイッターなど)